![Andrew Bishop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Bishop
Direttore Finanziario/CFO presso
ARCH BIOPARTNERS INC.
Patrimonio netto: 247 260 $ in data 31/05/2026
Profilo
Andrew Bishop is Chief Financial Officer & Executive Director at Arch Biopartners, Inc. since 2010.
Mr. Bishop is Principal at Bingley Capital, Inc. since 2009.
Former roles include Independent Director at Liminal BioSciences, Inc., Director at Willow Breast & Hereditary Cancer Support, Director at AmacaThera, Inc., Principal at Gordon Capital Corp., Principal at HSBC Securities (Canada), Inc., and Principal at First Marathon Securities Ltd. Education includes undergraduate studies at McGill University and an MBA from The Schulich School of Business, conferred in 1993.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/11/2025 | 780.000 ( 1,15% ) | 247 260 $ | 31/05/2026 |
Posizioni attive di Andrew Bishop
| Società | Posizione | Inizio |
|---|---|---|
| ARCH BIOPARTNERS INC. | Direttore Finanziario/CFO | 01/04/2010 |
Bingley Capital, Inc.
 Bingley Capital, Inc. Investment ManagersFinance Bingley Capital invests in small and medium scale companies with EBITDA of at least $2 million and sales of $10 to $100 million. The firm targets companies in the fields of industrial and Consumer Products. They do not invest in retailing, real estate, mining, oil & gas and technology-based companies. Bingley acquires controlling interests and provides financing in the form of equity & debt for buyout, MBO and growth capital requirements. | Investitore di Private Equity | 01/01/2009 |
Precedenti posizioni note di Andrew Bishop
| Società | Posizione | Fine |
|---|---|---|
AmacaThera, Inc.
 AmacaThera, Inc. Medical SpecialtiesHealth Technology Engages in developing and commercializing of injectable hydrogel platform technology for a wide range of medical applications | Direttore/Membro del Consiglio | - |
Willow Breast & Hereditary Cancer Support | Presidente | - |
Gordon Capital Corp.
 Gordon Capital Corp. Investment Banks/BrokersFinance Provides investing banking services | Corporate Officer/Principal | - |
HSBC Securities (Canada), Inc.
 HSBC Securities (Canada), Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
First Marathon Securities Ltd.
 First Marathon Securities Ltd. Investment Banks/BrokersFinance Provides security brokerage and flotation services | Corporate Officer/Principal | - |
Formazione di Andrew Bishop
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
22
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Gordon Capital Corp.
Gordon Capital Corp. Investment Banks/BrokersFinance Provides investing banking services | Finance |
HSBC Securities (Canada), Inc.
HSBC Securities (Canada), Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
First Marathon Securities Ltd.
First Marathon Securities Ltd. Investment Banks/BrokersFinance Provides security brokerage and flotation services | Finance |
Arch Biopartners, Inc.
 Arch Biopartners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops novel drugs | Health Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bingley Capital, Inc.
Bingley Capital, Inc. Investment ManagersFinance Bingley Capital invests in small and medium scale companies with EBITDA of at least $2 million and sales of $10 to $100 million. The firm targets companies in the fields of industrial and Consumer Products. They do not invest in retailing, real estate, mining, oil & gas and technology-based companies. Bingley acquires controlling interests and provides financing in the form of equity & debt for buyout, MBO and growth capital requirements. | Finance |
Willow Breast & Hereditary Cancer Support | |
AmacaThera, Inc.
AmacaThera, Inc. Medical SpecialtiesHealth Technology Engages in developing and commercializing of injectable hydrogel platform technology for a wide range of medical applications | Health Technology |
